A study of using the drug Sagenit in women reproductive age with climacteric syndrome was done. We observed 50 patients aged 37-49 years with climacteric disorders mild to moderate severity. Treatment lasts for a one month. Effectiveness of the drug was evaluated at 1 and 3 months after treatment. Sagenit proved highly effective in the treatment of «classical» estrogen deficiency manifestations (sweating and hot flushes), as well as in elimination of neurovegetative and psycho-emotional symptoms.There were not observed side effects and reactions of individual intolerance during monitoring of patients.The obtained results of the study demonstrate the feasibility of using the drug Sagenit in women reproductive age in order to correct menopausal disorders mild to moderate severity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.